Sue Foden – In Memoriam

Sue Foden, a member of our investment committee, unexpectedly deceased on Tuesday, November 4, 2024. Sue served as a member of our Investment Committee for almost 18 years and her invaluable contributions have played a pivotal role in shaping CD3 from its inception in 2006. Her guidance and unwavering commitment to excellence, in both scientific and business aspects, have been instrumental to our success. Sue will be profoundly missed.